Engineers Gate Manager LP Biogen Inc. Transaction History

Engineers Gate Manager LP

$7.46 Billion
Q2 2025

A detailed history of Engineers Gate Manager LP transactions in Biogen Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 33,008 shares of BIIB stock, worth $4.83 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

33,008

Previous 76,958 57.11%

Holding current value

$4.83 Million

Previous $10.5 Million 60.64%

% of portfolio

0.06%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$113.38 - $135.49 $4.98 Million - $5.95 Million	-43,950 Reduced 57.11%	33,008 $4.15 Million
Q1 2025 May 15, 2025	BUY	$133.43 - $153.27 $6.53 Million - $7.5 Million	48,915 Added 174.43%	76,958 $10.5 Million
Q4 2024 Feb 14, 2025	BUY	$146.47 - $191.55 $1.47 Million - $1.93 Million	10,051 Added 55.86%	28,043 $4.29 Million
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $3.4 Million - $4.26 Million	17,992 New	17,992 $3.49 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $8.45 Million - $10.7 Million	39,840 New	39,840 $8.59 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $727,091 - $828,491	-2,834 Reduced 45.01%	3,462 $962,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $920,648 - $1.12 Million	3,647 Added 137.67%	6,296 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $2.14 Million - $2.95 Million	-10,982 Reduced 80.57%	2,649 $707,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $430,404 - $511,830	2,295 Added 20.25%	13,631 $2.78 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.96 Million - $2.46 Million	10,095 Added 813.46%	11,336 $2.39 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $330,058 - $424,172	-1,474 Reduced 54.29%	1,241 $298,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $15,564 - $20,297	55 Added 2.07%	2,715 $768,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $688,940 - $1.1 Million	2,660 New	2,660 $921,000
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $3.14 Million - $3.67 Million	-12,908 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.6 Million - $3.92 Million	11,011 Added 580.44%	12,908 $3.16 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.86 Million - $2.15 Million	-7,041 Reduced 78.78%	1,897 $538,000
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $2.05 Million - $2.71 Million	7,908 Added 767.77%	8,938 $2.39 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $4.08 Million - $5.17 Million	-15,174 Reduced 93.64%	1,030 $326,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $793,976 - $1.1 Million	3,608 Added 28.64%	16,204 $4.81 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2.74 Million - $3.07 Million	12,596 New	12,596 $2.93 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $2.26 Million - $2.49 Million	-10,300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $2.23 Million - $3.49 Million	10,300 New	10,300 $2.44 Million

Others Institutions Holding BIIB

# of Institutions

1,030

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.54M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Biogen Inc. Transaction History